Skip to main content

Table 2 Baseline clinical characteristic of enrolled 35 patients

From: Assessment of left ventricular diastolic function after Transcatheter aortic valve implantation in aortic stenosis patients by echocardiographic according to different guidelines

Demographic data
 Agea (year)79.6 ± 4.3 (72–87)
 Femaleb n (%)15 (42.9)
 BMIa (kg/m2)22.9 ± 3.72
 Body surface areaa (m2)1.68 ± 0.18
 Heart ratea (beats/min)69.1 ± 10.8
 Systolic BPa (mmHg±SD)134.5 ± 2.9
 Diastolic BPa (mmHg±SD)65.7 ± 11.5
 Hemoglobina (g/L ± SD)114.6 ± 11.3
 Creatininea (mmol/L ± SD)81.5 ± 21.3
 STS scorea (%mortality±SD)8.8 ± 4.2
 EuroSCOREa3.6 ± 1.9
Artificial aortic valveb n (%)
 Medtronic Hancock II1(2.9)
 VENUS-A23 (65.7)
 J-Valve11 (31.4)
Medical historyb n (%)
 Hypertension17 (48.6)
 Diabetes9(25.7)
 Coronary heart disease (CHD)14 (40)
 Previous PCI3 (8.5)
 COPD6 (17.1)
Degree of mitral regurgitationb n (%)
 None/Mild22 (62.9)/13 (37.1)
 Mitral annular calcification n (%)17 (48.6)
NYHA functional classificationb n (%)
 I/II/III/IV0/8 (22.9)/24 (68.6)/3 (8.5)
Diastolic dysfunctionb n (%)
Normal/I/II/ III/Indeterminate7 (20)/7 (20)/14 (40)/5 (14)/2 (6)
  1. BP blood pressure; STS society of thoracic surgeons; PCI percutaneous coronary intervention; COPD chronic obstructive pulmonary disease; NYHA New York Heart Association;
  2. aData are mean ± SD with range in parentheses
  3. bData are raw number with percentage in parentheses